CIVAX Mutual Fund

NAV$22.31

Fund Essentials - as of Apr 30, 2026

Net Assets
-
Expense Ratio
0.92%
Dividend Yield (Current)
2.97%
Holdings
128
Inception Date
Nov 8, 2019
Fund Family
American Funds
Investment Style
PRO
Asset Class
PRO
Legal Structure
PRO
Dividend Frequency
Annually
SEC 30-Day Yield
PRO

Performance

YTD+5.66%
1 Year+13.27%
3 Year+12.33%
5 Year+6.22%

Asset Allocation

Stocks: 100.02%

Price Chart (6M)

Loading chart data...

Top Holdings

View All →
TickerNameWeight
ASML:ASASML HOLDING NV4.29%
TSM:TWTaiwan Semi. Mfg. Co., Adr2.79%
AZN:LNAstrazeneca Plc Adr2.58%
ABBN:SMABB Ltd. - Ordinary Shares1.18%
BATS:LNBritish American Tobacco P.l.c1.06%
Top 10 Concentration: 16.33%Report Date: Apr 30, 2026
Download all 128 holdings for CIVAX
CSV export with sector, industry & share changes
Get CSV

Dividend Summary

View Details →
Dividend Yield (Current)
2.97%
Frequency
Annually
Latest Distribution
$0.45
-

Peer Comparison

Benchmark
PRO
Peer outperformance: PRO
Category rank: PRO
This Mutual Fund
PRO
Peer Avg
PRO
See how CIVAX ranks against its peers
Category rank, peer-average returns and outperformance, updated daily.
$99/yr
7-day refund. Cancel anytime.
X-ray my whole portfolio
$99/yr Pro · 7-day refund. From MarketXLS, trusted since 2014.

CIVAX Mutual Fund Overview

CIVAX Mutual Fund (American Funds International Vantage Fund Class 529-A) is managed by American Funds. CIVAX expense ratio is 0.92%, holding 128 positions across sectors including Unknown, Information Technology, Industrials. Inception date: 2019-11-08.

CIVAX performance shows a YTD return of 5.66%. The 1-year return is 13.27% and the 5-year return is 6.22%. CIVAX dividend yield stands at 2.97%, paid annually.

CIVAX top holdings include ASML HOLDING NV (4.3%), Taiwan Semi. Mfg. Co., Adr (2.8%), Astrazeneca Plc Adr (2.6%), ABB Ltd. - Ordinary Shares (1.2%), British American Tobacco P.l.c (1.1%). View all CIVAX holdings, sector breakdown, or dividend history.

CIVAX can be compared against other funds using the overlap calculator or side-by-side comparison tool. CIVAX alternatives are available via the screener, along with tax-loss harvesting opportunities.